AG˹ٷ

STOCK TITAN

Ecovyst Reports Second Quarter 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Ecovyst (NYSE:ECVT) reported Q2 2025 results with sales of $200.1 million, up from $182.8 million in Q2 2024. Net income decreased to $6.0 million ($0.05 per share) from $8.3 million year-over-year. Adjusted EBITDA was $55.7 million with a 24.4% margin.

Key developments include the $35.0 million acquisition of Waggaman sulfuric acid assets and $21.9 million in share repurchases. The company maintained its midpoint guidance while tightening the full-year 2025 Adjusted EBITDA range to $242-254 million and increasing sales guidance to $795-835 million.

Ecoservices segment saw increased sales at $176.0 million, while Advanced Materials & Catalysts experienced lower sales due to timing of catalyst orders. The company maintains a strong liquidity position of $152.5 million with a net debt leverage ratio of 3.5x.

Ecovyst (NYSE:ECVT) ha riportato i risultati del secondo trimestre 2025 con vendite pari a 200,1 milioni di dollari, in aumento rispetto ai 182,8 milioni di dollari del secondo trimestre 2024. L'utile netto è diminuito a 6,0 milioni di dollari (0,05 dollari per azione) rispetto a 8,3 milioni di dollari dell'anno precedente. L'EBITDA rettificato è stato di 55,7 milioni di dollari con un margine del 24,4%.

Tra gli sviluppi principali, si segnala l'acquisizione da 35,0 milioni di dollari degli asset di acido solforico di Waggaman e 21,9 milioni di dollari in riacquisti di azioni. L'azienda ha mantenuto la guida al punto medio, restringendo l'intervallo dell'EBITDA rettificato per l'intero anno 2025 a 242-254 milioni di dollari e aumentando la previsione delle vendite a 795-835 milioni di dollari.

Il segmento Ecoservices ha registrato un aumento delle vendite a 176,0 milioni di dollari, mentre il settore Advanced Materials & Catalysts ha subito una diminuzione delle vendite a causa del timing degli ordini di catalizzatori. L'azienda mantiene una solida posizione di liquidità di 152,5 milioni di dollari con un rapporto di leva finanziaria netta di 3,5x.

Ecovyst (NYSE:ECVT) informó resultados del segundo trimestre de 2025 con ventas de 200,1 millones de dólares, frente a 182,8 millones en el segundo trimestre de 2024. El ingreso neto disminuyó a 6,0 millones de dólares (0,05 dólares por acción) desde 8,3 millones año tras año. El EBITDA ajustado fue de 55,7 millones de dólares con un margen del 24,4%.

Entre los desarrollos clave se incluye la adquisición de activos de ácido sulfúrico de Waggaman por 35,0 millones de dólares y 21,9 millones en recompras de acciones. La compañía mantuvo su guía en el punto medio, ajustando el rango de EBITDA ajustado para todo el año 2025 a 242-254 millones de dólares y aumentando la previsión de ventas a 795-835 millones de dólares.

El segmento Ecoservices vio un aumento en ventas a 176,0 millones de dólares, mientras que Advanced Materials & Catalysts experimentó menores ventas debido al momento de los pedidos de catalizadores. La empresa mantiene una sólida posición de liquidez de 152,5 millones de dólares con una ratio de apalancamiento de deuda neta de 3,5x.

Ecovyst (NYSE:ECVT)� 2025� 2분기 실적� 보고하며 매출액이 2� 100� 달러� 2024� 2분기 1� 8,280� 달러에서 증가했다� 밝혔습니�. 순이익은 전년 대� 600� 달러(주당 0.05달러)� 감소했습니다. 조정 EBITDA� 5,570� 달러� 24.4% 마진� 기록했습니다.

주요 발전 사항으로� 3,500� 달러 규모� Waggaman 황산 자산 인수2,190� 달러� 자사� 매입� 포함됩니�. 회사� 연간 2025� 조정 EBITDA 범위� 2� 4,200만~2� 5,400� 달러� 조정하면� 매출 가이던스를 7� 9,500만~8� 3,500� 달러� 상향 조정� 중간 목표치를 유지했습니다.

Ecoservices 부문은 매출� 1� 7,600� 달러� 증가했으�, Advanced Materials & Catalysts 부문은 촉매 주문 시기 영향으로 매출� 감소했습니다. 회사� 1� 5,250� 달러� 강력� 유동� 포지션을 유지하며 순부� 레버리지 비율은 3.5배입니다.

Ecovyst (NYSE:ECVT) a annoncé ses résultats du deuxième trimestre 2025 avec un chiffre d'affaires de 200,1 millions de dollars, en hausse par rapport à 182,8 millions de dollars au deuxième trimestre 2024. Le bénéfice net a diminué à 6,0 millions de dollars (0,05 dollar par action) contre 8,3 millions d'une année sur l'autre. L'EBITDA ajusté s'est élevé à 55,7 millions de dollars avec une marge de 24,4 %.

Les développements clés incluent l'acquisition pour 35,0 millions de dollars des actifs d'acide sulfurique de Waggaman et 21,9 millions de dollars en rachats d'actions. La société a maintenu sa prévision médiane tout en resserrant la fourchette d'EBITDA ajusté pour l'année complète 2025 à 242-254 millions de dollars et en augmentant ses prévisions de ventes à 795-835 millions de dollars.

Le segment Ecoservices a vu ses ventes augmenter à 176,0 millions de dollars, tandis que Advanced Materials & Catalysts a connu une baisse des ventes due au calendrier des commandes de catalyseurs. L'entreprise maintient une solide position de liquidité de 152,5 millions de dollars avec un ratio d'endettement net de 3,5x.

Ecovyst (NYSE:ECVT) meldete die Ergebnisse für das zweite Quartal 2025 mit einem Umsatz von 200,1 Millionen US-Dollar, gegenüber 182,8 Millionen US-Dollar im zweiten Quartal 2024. Der Nettogewinn sank auf 6,0 Millionen US-Dollar (0,05 US-Dollar pro Aktie) von 8,3 Millionen US-Dollar im Vorjahresvergleich. Das bereinigte EBITDA betrug 55,7 Millionen US-Dollar bei einer Marge von 24,4 %.

Wichtige Entwicklungen umfassen den 35,0 Millionen US-Dollar Erwerb der Waggaman-Schwefelsäureanlagen und 21,9 Millionen US-Dollar an Aktienrückkäufen. Das Unternehmen hielt seine Guidance in der Mitte bei, straffte jedoch die bereinigte EBITDA-Spanne für das Gesamtjahr 2025 auf 242-254 Millionen US-Dollar und erhöhte die Umsatzprognose auf 795-835 Millionen US-Dollar.

Das Ecoservices-Segment verzeichnete einen Umsatzanstieg auf 176,0 Millionen US-Dollar, während Advanced Materials & Catalysts aufgrund des Zeitpunktes der Katalysatorbestellungen geringere Umsätze verzeichnete. Das Unternehmen hält eine starke Liquiditätsposition von 152,5 Millionen US-Dollar mit einem Nettoverschuldungsgrad von 3,5x.

Positive
  • Sales increased 9.5% year-over-year to $200.1 million in Q2 2025
  • Strategic acquisition of Waggaman sulfuric acid assets for $35.0 million
  • Strong share repurchase program with $21.9 million executed in Q2
  • Ecoservices segment showed growth with favorable pricing in regeneration services
  • Maintained solid liquidity position of $152.5 million
Negative
  • Net income declined 27.7% to $6.0 million from $8.3 million year-over-year
  • Adjusted Free Cash Flow turned negative at $(2.4) million vs $14.4 million in prior year
  • Net debt leverage ratio increased to 3.5x
  • Lower sales volume in Advanced Materials & Catalysts segment
  • Potential impact from tariffs estimated at $2-3 million for 2025

Insights

Ecovyst delivers mixed Q2 results with revenue growth offset by profit decline; maintains 2025 guidance amid acquisition integration challenges.

Ecovyst reported Q2 sales of $200.1 million, up 9.5% year-over-year, but net income declined to $6.0 million from $8.3 million in the prior year, reflecting margin pressure. The company's Adjusted EBITDA of $55.7 million was at the high end of guidance but still slightly below last year's $56.9 million, with margins compressing to 24.4%.

The Ecoservices segment showed sales growth of 14.4% to $176.0 million, benefiting from higher sulfur costs pass-through, favorable regeneration services pricing, and contribution from the newly acquired Waggaman assets. However, volume declines in regeneration services due to unplanned customer downtime limited Adjusted EBITDA growth to just $0.1 million.

The Advanced Materials & Catalysts segment faced headwinds with sales dropping 16.6% to $24.1 million, primarily due to timing of niche custom catalyst orders. The Zeolyst Joint Venture saw a slight sales decrease of 2.1%, resulting in segment Adjusted EBITDA declining by $1.0 million.

Cash flow metrics show some deterioration, with operating cash flow decreasing to $43.3 million for the first half compared to $46.4 million in 2024. More concerning is the negative Adjusted Free Cash Flow of $2.4 million versus positive $14.4 million last year, reflecting integration costs and higher capital expenditures.

The $35.0 million Waggaman acquisition (plus $6.3 million in working capital adjustments) represents a strategic expansion of sulfuric acid production capacity, but management admits integration costs are offsetting near-term sales benefits. The company's leverage ratio increased to 3.5x, a level that limits financial flexibility.

Despite these challenges, management maintained the midpoint of its full-year Adjusted EBITDA guidance while narrowing the range to $242-254 million. The active share repurchase program continues, with $21.9 million spent to buy back 2.9 million shares at an average price of $7.47 per share, demonstrating management's confidence in long-term value.

The company faces some headwinds, including potential tariff impacts of $2-3 million on the Advanced Materials & Catalysts segment and uncertainty around global polyethylene demand. Management's guidance assumes refinery utilization will remain high and sulfuric acid demand will grow in the second half, particularly in mining applications.

WAYNE, Pa., Aug. 7, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading integrated and innovative global provider of advanced materials, specialty catalysts, virgin sulfuric acid and sulfuric acid regeneration services, today reported results for the second quarter ended June 30, 2025.

Second Quarter2025 Results & Highlights

  • Sales of $200.1 million, compared to $182.8 million in the second quarter of 2024
  • Net Income of $6.0 million, compared to $8.3 million in the year-ago quarter, with a net income margin of 3.0% and diluted net income per share of $0.05. Adjusted Net Income was $13.7 million with Adjusted Diluted Income per share of $0.12
  • Adjusted EBITDA of $55.7 million, compared to $56.9 million in the second quarter of 2024, with an Adjusted EBITDA margin of 24.4%
  • Cash flows from operating activities were $43.3 million for the six months ended June 30, 2025, compared to $46.4 million for the six months ended June 30, 2024. Adjusted Free Cash Flow was $(2.4) million for the six months ended June 30, 2025, compared to $14.4 million for the six months ended June 30, 2024
  • Completed the acquisition of the Waggaman, Louisiana sulfuric acid production assets from Cornerstone Chemical Company for $35.0 million and customary working capital adjustments of $6.3 million
  • Repurchased $21.9 million of common stock

"Weare pleased with our results for the second quarter of 2025. With demand fundamentals generally in line with our expectations, we delivered Adjusted EBITDA of $55.7 million, at the high end of our guidance range. Following a strong first half, we anticipate sustained demand within our Ecoservices segment for the remainder of 2025, and have secured a solid pipeline of orders for our differentiated hydrocracking catalysts. As a result, we are maintaining the midpoint of our prior guidance range for full-year 2025 Adjusted EBITDA, while tightening the guidance range to reflect first half results and our expectations for the balance of the year," said Kurt J. Bitting, Ecovyst's Chief Executive Officer.

"During the second quarter we completed the acquisition of the Waggaman, Louisiana sulfuric acid production assets from Cornerstone Chemical Company. We remain confident that Ecovyst will capture meaningful future benefits and synergies from the acquisition as we continue integrating these assets into Ecoservices in 2025. In addition, with our continued focus on delivering value for our stockholders, during the quarter we repurchased 2.9 million shares of common stock, totaling approximately $22 million," said Bitting. "Lastly, with regard to the strategic review of our Advanced Materials & Catalysts segment, we continue to make steady progress and anticipate providing an update in the near future."

Review of Segment Results and Business Trends

Ecoservices

Secondquarter 2025 sales for Ecoservices were $176.0 million, compared to $153.9 million in the second quarter of 2024. The increase in sales reflects the pass-through effect of higher sulfur costs, favorable contractual pricing for regeneration services, strong pricing in virgin sulfuric acid, and the sales contribution from the Waggaman sulfuric acid assets, partially offset by lower sales volume for regeneration services driven by unplanned and extended customer downtime. Second quarter 2025 Adjusted EBITDA for Ecoservices was $49.8 million, compared to $49.7 million in the second quarter of 2024, with the favorable contract pricing for regeneration services, strong pricing in virgin sulfuric acid, along with lower turnaround costs, largely offset by lower regeneration services volume and higher anticipated manufacturing costs driven by general inflation.

Advanced Materials & Catalysts

During the second quarter of 2025, Advanced Silicas sales were $24.1 million, compared to $28.9 million in the second quarter of 2024. The decrease in sales was primarily the result of lower event-driven niche custom catalyst sales related to order timing. Our proportionate 50% share of second quarter sales for the Zeolyst Joint Venture was $28.4 million, compared to $29.0 million in the second quarter of 2024. The slight reduction in Zeolyst Joint Venture sales reflects lower sales of hydrocracking catalysts and custom catalysts, reflective of sales timing, partially offset by higher sales of catalysts used in the production of sustainable fuels and other specialty catalyst sales. Second quarter 2025 Adjusted EBITDA for Advanced Materials & Catalysts, which includes our 50% proportionate share of earnings from the Zeolyst Joint Venture, was $13.7 million, compared to $14.7 million in the second quarter of 2024, with the decrease largely driven by lower sales volume and mix due to the timing of niche custom catalyst sales within Advanced Silicas.

Cash Flows and Balance Sheet

Cash flows from operating activities was $43.3 million for the six months ended June 30, 2025, compared to $46.4 million for the six months ended June 30, 2024. The decrease was primarily driven by the timing of dividends received from the Zeolyst Joint Venture and lower earnings, partially offset by the change in working capital. At June 30, 2025, the Company had cash and cash equivalents of $69.6 million, total gross debt of $866.5 million and availability under the ABL facility of $82.9 million, after giving effect to $3.3 million of outstanding letters of credit and with no revolving credit facility borrowings outstanding, for total available liquidity of $152.5 million. The net debt to net income ratio for the trailing twelve months was not meaningful as of June 30, 2025 and the net debt leverage ratio for the trailing twelve months was 3.5x as of June 30, 2025.

2025 Financial Outlook

We are maintaining the midpoint of our full-year 2025 Adjusted EBITDA guidance range while tightening the range to reflect results for the first half of the year, and expectations for the balance of the year. In addition, we are increasing the sales guidance range to reflect factors including the acquisition of the Waggaman sulfuric acid assets. Although we expect the acquisition of the Waggaman sulfuric acid assets to contribute positively to Ecoservices' sales for the remainder of the year, we expect the sales contribution will be largely offset by incremental costs, including costs for integration and upgrading the facility. In anticipation of continued high refinery utilization and growth in sulfuric acid demand, particularly in mining applications, we expect Ecoservices to benefit from higher sales volumes for both regeneration services and for virgin sulfuric acid in the second half of 2025, along with continued favorable pricing. For Advanced Silicas, we expect that our polyethylene catalyst sales will continue to outpace growth in global demand, with sales of polyethylene catalysts and supports in 2025 reflecting year-over-year growth compared to 2024. However, we remain cautious about the potential for global polyethylene demand to be adversely impacted by factors including tariffs and deterioration in global macroeconomic conditions. Within the Zeolyst Joint Venture, we currently anticipate year-over-year sales growth in 2025, compared to 2024, driven by positive momentum in hydrocracking catalyst sales. And while we believe the supply and demand imbalance will remain a factor for near-term sales of catalyst materials used in the production of sustainable fuels, we continue to expect our sales of sustainable fuel catalysts will be flat to slightly up in 2025, compared to 2024.

"Regarding tariffs, proposed tariff levels are still subject to change, and there remains the possibility of incremental demand disruption related to tariffs. Nevertheless, as mentioned in our first quarter earnings call, we maintain the view that the direct impact of current tariffs is limited to approximately $2 million to $3 million in 2025 withinEcovyst's Advanced Materials & Catalysts segment. Furthermore, while we are maintaining our full-year guidance for Sales and Adjusted EBITDA, our full-year outlook does not incorporate the effect of any significant macroeconomic impacts or related demand fluctuations that could result from prolonged tariff uncertainty," said Bitting.

The Company's current guidance for full year 2025 is as follows:

  • Sales of $795 million to $835 million1 (change from $785 million to $845 million)
  • Sales of $125 million to $140 million for proportionate 50% share ofZeolyst Joint Venture, which is excluded from GAAP Sales (change from $115 million to $130 million)
  • Adjusted EBITDA2 of $242 million to $254 million (change from $238 million to $258 million)
  • Adjusted Free Cash Flow2 of $70 million to $80 million (change from $60 million to $80 million)
  • Capital expenditures of $80 million to $90 million
  • Interest expense of $46 million to $50 million (change from $47 million to $53 million)
  • Depreciation & Amortization
    • Ecovyst - $92 million to $98 million (change from $87 million to $93 million)
    • Zeolyst J.V. - $12 million to $14 million
  • Effective tax rate in the mid 20% range
  • Adjusted Net Income2 of $60 million to $80 million, with Adjusted Diluted Income2 per share of $0.52 to $0.68 (change from $58 million to $85 million and $0.50 to $0.70)

The Company's guidance for the third quarter of 2025 is as follows:

  • Adjusted EBITDA2 of $62 million to $72 million

1Sales outlook for 2025 assumes higher average sulfur prices compared to 2024 and higher projected pass-through of sulfur costs of approximately $65 million.

2In reliance upon the unreasonable efforts exemption provided under Item 10(e)(1)(i)(B) of Regulation S-K, the Company is not able to provide a reconciliation of its non-GAAP financial guidance to the corresponding GAAP measures without unreasonable effort because of the inherent difficulty in forecasting and quantifying certain amounts necessary for such a reconciliation such as certain non-cash, nonrecurring or other items that are included in net income and net cash provided by operating activities as well as the related tax impacts of these items and asset dispositions / acquisitions and changes in foreign currency exchange rates that are included in cash flow, due to the uncertainty and variability of the nature and amount of these future charges and costs. Because this information is uncertain, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

Stock Repurchase

In April 2022, the Company's Board of Directors approved a stock repurchase program authorizing the repurchase of up to $450 million of the Company's outstanding common stock over the next four years. As of June 30, 2025, $207.7 million was available for share repurchases under the program.

During the second quarter of 2025, the Company repurchased 2,926,152 shares of its common stock on the open market at an average price of $7.47 per share, for a total cost of $21.9 million.

During the second quarter of 2024, the Company repurchased 552,081 shares of its common stock on the open market at an average price of $9.05 per share, for a total cost of $5.0 million.

For possible future repurchases, the actual timing, number, and nature of shares repurchased will depend on a variety of factors, including stock price, trading volume, and general business and market conditions and may be conducted through negotiated transactions, open market repurchases or other means, including through Rule 10b-18 and Rule 10b5-1 trading plans or accelerated share repurchases. The repurchase program does not obligate the Company to acquire any number of shares in any specific period, or at all, and the repurchase program may be amended, suspended or discontinued at any time at the Company's discretion.

Conference Call and Webcast Details

On Thursday, August7, 2025, Ecovyst management will review the second quarter 2025 results during a conference call and audio-only webcast scheduled for 11:00 a.m. Eastern Time.

Conference Call: Investors may listen to the conference call live via telephone by dialing 1 (800) 245-3047 (domestic) or
1 (203) 518-9765(international) and use the participant code ECVTQ225.

Webcast: An audio-only live webcast of the conference call and presentation materials can be accessed at .A replay of the conference call/webcast will be made available at .

Investor Contact:

Gene Shiels
(484) 617-1225
[email protected]

About Ecovyst Inc.

Ecovyst Inc. and subsidiaries is a leading integrated and innovative global provider of advanced materials, specialty catalysts, virgin sulfuric acid and sulfuric acid regeneration services. We support customers globally through our strategically located network of manufacturing facilities. We believe that our products and services contribute to improving the sustainability of the environment.

We have two uniquely positioned specialty businesses: Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides high quality and high strength virgin sulfuric acid for industrial and mining applications. Ecoservices also provides chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry. Advanced Materials & Catalysts, through its Advanced Silicas business, provides finished silica catalysts, catalyst supports and functionalized silicas necessary to produce high performing plastics and to enable sustainable chemistry, and through its Zeolyst Joint Venture, innovates and supplies specialty zeolites used in catalysts that support the production of sustainable fuels, remove nitrogen oxides from diesel engine emissions and that are broadly applied in refining and petrochemical processes. For more information, see our website at .

Presentation of Non-GAAP Financial Measures

In addition to the results provided in accordance with U.S. generally accepted accounting principles ("GAAP") throughout this press release, the Company has provided non-GAAP financial measures � Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Diluted Income per share, Net Debt to Net Income ratio and Net Debt Leverage Ratio (collectively, "Non-GAAP Financial Measures") � which present results on a basis adjusted for certain items. The Company uses these Non-GAAP Financial Measures for business planning purposes and in measuring its performance relative to that of its competitors. The Company believes that these Non-GAAP Financial Measures are useful financial metrics to assess its operating performance from period-to-period by excluding certain items that the Company believes are not representative of its core business. These Non-GAAP Financial Measures are not intended to replace, and should not be considered superior to, the presentation of the Company's financial results in accordance with GAAP. The use of the Non-GAAP Financial Measures terms may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. These Non-GAAP Financial Measures are reconciled from the respective measures under GAAP in the attached appendix.

Zeolyst Joint Venture

The Company's zeolite catalysts product group operates through its Zeolyst Joint Venture, which is accounted for as an equity method investment in accordance with GAAP. The presentation of the Zeolyst Joint Venture's sales represents 50% of the sales of the Zeolyst Joint Venture. The Company does not record its proportionate share of sales from the Zeolyst Joint Venture accounted for using the equity method as revenue and such sales are not consolidated within its results of operations. However, Adjusted EBITDA for the Company's Advanced Materials & Catalysts segment reflects the Company's 50% portion of the earnings from the Zeolyst Joint Venture that have been recorded as equity in net income in the Company's condensed consolidated statements of income for such periods and includes Zeolyst Joint Venture adjustments on a proportionate basis based on the Company's 50% ownership interest. Accordingly, the Company's Adjusted EBITDA margins are calculated including 50% of the sales of the Zeolyst Joint Venture for the relevant periods in the denominator.

Note on Forward-Looking Statements

Some of the information contained in this press release constitutes "forward-looking statements." Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "projects" and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Examples of forward-looking statements include, but are not limited to, statements regarding our future results of operations, financial condition, capital expenditure projects, liquidity, prospects, growth, strategies, capital allocation program (including the stock repurchase program), product and service offerings, expected demand trends, the timing and outcome, if any, of our strategic review process for our Advanced Materials & Catalysts segment, the impact of the acquisition of the Waggaman sulfuric acid assets, the effect of tariffs on our business and results and our third quarter and full year 2025 financial outlook. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, regional, national or global political, economic, business, competitive, market and regulatory conditions, including the enactment, schedule and impact of tariffs and trade disputes, currency exchange rates, the effects of inflation, the timing and outcome, if any, of our strategic review process for our Advanced Materials & Catalysts segment, and other factors, including those described in the sections titled "Risk Factors" and "Management's Discussion & Analysis of Financial Condition and Results of Operations" in our filings with the SEC, which are available on the SEC's website at . These forward-looking statements speak only as of the date of this release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

ECOVYST INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, except share and per share amounts)




Three months ended

June 30,




Six months ended

June 30,





2025


2024


% Change


2025


2024


% Change




Sales


$ 200.1


$ 182.8


9.5%


$ 362.3


$ 343.4


5.5%

Cost of goods sold


150.4


129.1


16.5%


287.0


250.5


14.6%

Gross profit


49.7


53.7


(7.4)%


75.3


92.9


(18.9)%

Selling, general and administrative expenses


22.7


22.7


—�%


44.0


44.3


(0.7)%

Other operating expense, net


9.2


3.1


196.8%


14.4


6.8


111.8%

Operating income


17.8


27.9


(36.2)%


16.9


41.8


(59.6)%

Equity in net (income) from affiliated companies


(1.9)


(1.4)


35.7%


(10.8)


(3.5)


208.6%

Interest expense, net


11.1


12.9


(14.0)%


22.1


26.3


(16.0)%

Debt modification and extinguishment costs



4.6


(100.0)%


1.0


4.6


(78.3)%

Other expense, net


0.6


0.4


50.0%


0.7


0.6


16.7%

Income before income taxes


8.0


11.4


(29.8)%


3.9


13.8


(71.7)%

Provision for income taxes


2.0


3.1


(35.5)%


1.5


4.3


(65.1)%

Effective tax rate


25.6%


27.1%




38.8%


30.9%



Net income


$ 6.0


$ 8.3


(27.7)%


$ 2.4


$ 9.5


(74.7)%














Earnings per share:













Basic earnings per share


$ 0.05


$ 0.07




$ 0.02


$ 0.08



Diluted earnings per share


$ 0.05


$ 0.07




$ 0.02


$ 0.08
















Weighted average shares outstanding:













Basic


116,232,528


116,912,332




116,745,476


116,935,708



Diluted


116,535,060


117,635,289




117,044,461


117,545,240



ECOVYST INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share amounts)



June 30,
2025


December 31,
2024

ASSETS




Cash and cash equivalents

$ 69.6


$ 146.0

Accounts receivable, net

103.5


77.9

Inventories, net

66.9


57.1

Derivative assets

4.0


6.5

Prepaid and other current assets

25.4


16.1

Total current assets

269.4


303.6

Investments in affiliated companies

346.5


349.3

Property, plant and equipment, net

602.9


569.3

Goodwill

406.7


404.1

Other intangible assets, net

94.8


98.4

Right-of-use lease assets

37.1


33.6

Other long-term assets

39.0


44.0

Total assets

$ 1,796.4


$ 1,802.3

LIABILITIES




Current maturities of long-term debt

$ 8.7


$ 8.7

Accounts payable

47.9


43.9

Operating lease liabilities—current

9.0


9.3

Accrued liabilities

54.0


53.2

Total current liabilities

119.6


115.1

Long-term debt, excluding current portion

847.9


852.1

Deferred income taxes

104.6


105.4

Operating lease liabilities—noncurrent

28.2


24.2

Other long-term liabilities

3.7


5.0

Total liabilities

1,104.0


1,101.8

Commitments and contingencies




EQUITY




Common stock ($0.01 par); authorized shares 450,000,000; issued shares 140,872,846 and 140,872,846
on June 30, 2025 and December 31, 2024, respectively; outstanding shares 114,487,661 and 116,534,803
on June 30, 2025 and December 31, 2024, respectively

1.4


1.4

Preferred stock ($0.01 par); authorized shares 50,000,000; no shares issued or outstanding on June 30,
2025 and December 31, 2024


Additional paid-in capital

1,103.5


1,106.8

Accumulated deficit

(175.1)


(177.5)

Treasury stock, at cost; shares 26,385,185 and 24,338,043 on June 30, 2025 and December 31, 2024,
respectively

(236.6)


(222.8)

Accumulated other comprehensive loss

(0.8)


(7.4)

Total equity

692.4


700.5

Total liabilities and equity

$ 1,796.4


$ 1,802.3

ECOVYST INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS



Six months ended

June 30,


2025


2024

Cash flows from operating activities:

(in millions)

Net income

$ 2.4


$ 9.5

Adjustments to reconcile net income to net cash provided by operating activities:




Depreciation

40.0


36.5

Amortization

7.0


7.0

Amortization of deferred financing costs and original issue discount

0.7


1.1

Debt extinguishment costs


0.1

Foreign currency exchange loss

0.4


0.2

Deferred income tax provision (benefit)

1.4


(1.7)

Net loss on asset disposals

0.4


0.6

Stock compensation

6.5


7.5

Equity in net (income) from affiliated companies

(10.8)


(3.5)

Dividends received from affiliated companies

20.0


33.0

Other, net

(0.1)


2.3

Working capital changes that provided (used) cash:




Receivables

(15.0)


(4.1)

Inventories

(6.0)


(6.7)

Prepaids and other current assets

(2.5)


(4.5)

Accounts payable

6.5


(3.3)

Accrued liabilities

(7.6)


(27.6)

Net cash provided by operating activities

43.3


46.4





Cash flows from investing activities:




Purchases of property, plant and equipment

(49.5)


(36.6)

Business combinations

(41.3)


Other, net


(0.2)

Net cash used in investing activities

(90.8)


(36.8)





Cash flows from financing activities:




Issuance of long-term debt, net of original issue discount and financing fees

870.8


870.8

Repayments of long-term debt

(875.2)


(877.5)

Repurchases of common shares

(21.9)


(5.0)

Tax withholdings on equity award vesting

(1.5)


(1.2)

Repayment of financing obligation

(1.6)


(1.5)

Net cash used in financing activities

(29.4)


(14.4)





Effect of exchange rate changes on cash and cash equivalents

0.5


(0.3)

Net change in cash and cash equivalents

(76.4)


(5.1)

Cash and cash equivalents at beginning of period

146.0


88.4

Cash and cash equivalents at end of period

$ 69.6


$ 83.3

Appendix Table A-1: Reconciliation of Net Income (Loss) to Adjusted EBITDA




Three months ended

June 30,


Six months ended

June 30,



2025


2024


2025


2024



(in millions)

Reconciliation of net income to Adjusted EBITDA









Net income


$ 6.0


$ 8.3


$ 2.4


$ 9.5

Provision for income taxes


2.0


3.1


1.5


4.3

Interest expense, net


11.1


12.9


22.1


26.3

Depreciation and amortization


23.9


21.6


47.1


43.6

EBITDA


43.0


45.9


73.1


83.7

Joint venture depreciation, amortization and interest(a)


3.2


3.2


6.3


6.5

Amortization of investment in affiliate step-up(b)


0.6


0.9


1.2


2.5

Debt modification and extinguishment costs



4.6


1.0


4.6

Net loss on asset disposals(d)


0.3



0.4


0.6

Foreign currency exchange (gain) loss(e)



(0.1)


0.1


0.1

LIFO benefit(f)


(0.4)


(1.5)


(1.2)


(2.7)

Transaction and other related costs(g)


2.7


0.1


4.5


0.2

Equity-based compensation


3.4


3.8


6.5


7.5

Restructuring, integration and business optimization expenses(h)


1.0


0.2


1.2


0.4

Other(i)


1.9


(0.2)


1.5


(1.0)

Adjusted EBITDA


$ 55.7


$ 56.9


$ 94.6


$ 102.4



Trailing twelve months ended
June 30,



2025


2024



(in millions)

Reconciliation of net (loss) income to Adjusted EBITDA





Net (loss) income


$ (13.8)


$ 56.1

(Benefit) provision for income taxes


(1.3)


5.4

Interest expense, net


45.2


52.0

Depreciation and amortization


92.8


86.9

EBITDA


122.9


200.4

Joint venture depreciation, amortization and interest(a)


13.2


13.1

Amortization of investment in affiliate step-up(b)


2.4


5.7

Impairment of investment in affiliated companies(c)


65.0


Intangible asset impairment charge


3.9


Debt modification and extinguishment costs


1.0


4.6

Net loss on asset disposals(d)


2.3


2.4

Foreign currency exchange gain(e)


(0.2)


LIFO benefit(f)


(0.8)


(1.6)

Transaction and other related costs(g)


4.8


0.6

Equity-based compensation


13.0


14.4

Restructuring, integration and business optimization expenses(h)


1.7


1.0

Other(i)


1.1


(0.5)

Adjusted EBITDA


$ 230.3


$ 240.1

Descriptions toEcovyst Non-GAAP Reconciliations

(a)

We use Adjusted EBITDA as a performance measure to evaluate our financial results. Because our Advanced Materials &
Catalysts segment reflects our 50% portion of the earnings from the Zeolyst Joint Venture, we include an adjustment for our
50% proportionate share of depreciation, amortization and interest expense of the Zeolyst Joint Venture.

(b)

Represents the amortization of the fair value adjustments associated with the equity affiliate investment in the Zeolyst Joint
Venture as a result of the combination of the businesses of PQ Holdings Inc. and Eco Services Operations LLC in May
2016. We determined the fair value of the equity affiliate investment and the fair value step-up was then attributed to the
underlying assets of the Zeolyst Joint Venture. Amortization is primarily related to the fair value adjustments associated
with intangible assets, including customer relationships and technical know-how.

(c)

Represents fair value impairments associated with the equity affiliate investment in the Zeolyst Joint Venture. During the
year ended December 31, 2024, we recognized an impairment charge on our investment in the Zeolyst Joint Venture to
reduce the carrying value of our investment to its estimated fair value. This impairment was a partial reduction to the
goodwill and trade name components of the purchase accounting fair value adjustments recorded as a result of the
combination of the businesses of PQ Holdings Inc. and Eco Services Operations LLC in May 2016.

(d)

When asset disposals occur, we remove the impact of net gain/loss of the disposed asset because such impact primarily
reflects the non-cash write-off of long-lived assets no longer in use.

(e)

Reflects the exclusion of the foreign currency transaction gains and losses in the condensed consolidated statements of
income related to the remeasurement effects of monetary assets and liabilities, including non-permanent intercompany debt,
denominated in foreign currency.

(f)

Represents non-cash adjustments to the Company's LIFO reserves for certain inventories in the U.S. that are valued using
the LIFO method, effectively reflecting the results as if these inventories were valued using the FIFO method, which we
believe provides a means of comparison to other companies that may not use the same basis of accounting for inventories.

(g)

Relates to certain transaction costs, including debt financing, due diligence and other costs related to transactions that are
completed, pending or abandoned, that we believe are not representative of our ongoing business operations.

(h)

Includes the impact of restructuring, integration and business optimization expenses, which are incremental costs that are
not representative of our ongoing business operations.

(i)

Other consists of adjustments for items that are not core to our ongoing business operations. These adjustments include
environmental remediation and other legal costs, expenses for capital and franchise taxes, and defined benefit pension and
postretirement plan (benefits) costs, for which our obligations are under plans that are frozen. Also included in this amount
are adjustments to eliminate the benefit realized in cost of goods sold of the allocation of a portion of the contract
manufacturing payments under the five-year agreement with the buyer of the Performance Chemicals business to the
financing obligation under the failed sale-leaseback. Included in this line-item are rounding discrepancies that may arise
from rounding from dollars (in thousands) to dollars (in millions).

Appendix Table A-2: Reconciliation of Net Income and EPS to Adjusted Net Income and Adjusted EPS(1)



Three months ended June 30,


2025


2024


Pre-tax
amount

Tax
expense
(benefit)

After-tax
amount

Per share,
basic

Per share,
diluted


Pre-tax
amount

Tax
expense
(benefit)

After-tax
amount

Per share,
basic

Per share,
diluted


(in millions, except share and per share amounts)

Net income

$ 8.0

$ 2.0

$ 6.0

$ 0.05

$ 0.05


$ 11.4

$ 3.1

$ 8.3

$ 0.07

$ 0.07

Amortization of investment
in affiliate step-up(b)

0.6

0.1

0.5


0.9

0.2

0.7

0.01

0.01

Debt modification and
extinguishment costs


4.6

1.2

3.4

0.03

0.03

Net loss on asset disposals(d)

0.3

0.1

0.2


Foreign currency exchange
gain(e)


(0.1)

(0.1)

LIFO benefit(f)

(0.4)

(0.1)

(0.3)


(1.5)

(0.3)

(1.2)

(0.01)

(0.01)

Transaction and other related costs(g)

2.7

0.6

2.1

0.02

0.02


0.1

0.1

Equity-based compensation

3.4

0.4

3.0

0.03

0.03


3.8

0.9

2.9

0.02

0.02

Restructuring, integration
and business optimization
expenses(h)

1.0

0.2

0.8

0.01

0.01


0.2

0.1

0.1

Other(i)

1.9

0.5

1.4

0.01

0.01


(0.2)

(0.1)

(0.1)

Adjusted Net Income(1)

$ 17.5

$ 3.8

$ 13.7

$ 0.12

$ 0.12


$ 19.2

$ 5.1

$ 14.1

$ 0.12

$ 0.12













Weighted average shares
outstanding




116,232,528

116,535,060





116,912,332

117,635,289














Six months ended June 30,


2025


2024


Pre-tax
amount

Tax
expense
(benefit)

After-tax
amount

Per share,
basic

Per share,
diluted


Pre-tax
amount

Tax
expense
(benefit)

After-tax
amount

Per share,
basic

Per share,
diluted


(in millions, except share and per share amounts)

Net income

$ 3.9

$ 1.5

$ 2.4

$ 0.02

$ 0.02


$ 13.8

$ 4.3

$ 9.5

$ 0.08

$ 0.08

Amortization of investment
in affiliate step-up(b)

1.2

0.3

0.9

0.01

0.01


2.5

0.6

1.9

0.02

0.02

Debt modification and
extinguishment costs

1.0

0.2

0.8

0.01

0.01


4.6

1.2

3.4

0.03

0.03

Net loss on asset disposals(d)

0.4

0.1

0.3


0.6

0.1

0.5

Foreign currency exchange
loss(e)

0.1

0.1


0.1

0.1

LIFO benefit(f)

(1.2)

(0.3)

(0.9)

(0.01)

(0.01)


(2.7)

(0.7)

(2.0)

(0.02)

(0.02)

Transaction and other related costs(g)

4.5

1.1

3.4

0.03

0.03


0.2

0.1

0.1

Equity-based compensation

6.5

0.3

6.2

0.05

0.05


7.5

1.4

6.1

0.05

0.05

Restructuring, integration
and business optimization
expenses(h)

1.2

0.3

0.9

0.01

0.01


0.4

0.1

0.3

Other(i)

1.5

0.4

1.1

0.01

0.01


(1.0)

(0.3)

(0.7)

Adjusted Net Income(1)

$ 19.1

$ 3.9

$ 15.2

$ 0.13

$ 0.13


$ 26.0

$ 6.8

$ 19.2

$ 0.16

$ 0.16













Weighted average shares
outstanding




116,745,476

117,044,461





116,935,708

117,545,240

See Appendix Table A-1 for Descriptions toEcovyst Non-GAAP Reconciliations in the table above.

(1)

We define Adjusted Net Income as net income adjusted for non-operating income or expense and the impact of certain non-
cash or other items that are included in net income that we do not consider indicative of our ongoing operating performance.
Adjusted Net Income is presented as a key performance indicator as we believe it will enhance a prospective investor's
understanding of our results of operations and financial condition. Adjusted Net Income may not be comparable with net
income or Adjusted Net Income as defined by other companies.

The adjustments to net income are shown net of applicable tax rates of 23.8% and 25.1% for the six months ended June 30, 2025 and 2024, respectively, except for equity-based compensation. The tax effect on equity-based compensation is derived by removing the tax effect of any equity-based compensation expense disallowed as a result of its inclusion within IRC Sec. 162(m), and adding the tax effect of equity-based stock compensation shortfall recorded as a discrete item.

Appendix Table A-3: Sales and Adjusted EBITDA by Business Segment




Three months ended

June 30,




Six months ended

June 30,





2025


2024


% Change


2025


2024


% Change




Sales:













Ecoservices


$ 176.0


$ 153.9


14.4%


$ 319.1


$ 295.6


7.9%

Advanced Materials & Catalysts(1)


24.1


28.9


(16.6)%


43.2


47.8


(9.6)%

Total sales


$ 200.1


$ 182.8


9.5%


$ 362.3


$ 343.4


5.5%














Zeolyst Joint Venture sales


$ 28.4


$ 29.0


(2.1)%


$ 66.2


$ 52.5


26.1%














Adjusted EBITDA:













Ecoservices


$ 49.8


$ 49.7


0.2%


$ 78.3


$ 91.2


(14.1)%

Advanced Materials & Catalysts


13.7


14.7


(6.8)%


31.2


25.8


20.9%

Unallocated corporate expenses


(7.8)


(7.5)


(4.0)%


(14.9)


(14.6)


(2.1)%

Total Adjusted EBITDA


$ 55.7


$ 56.9


(2.1)%


$ 94.6


$ 102.4


(7.6)%














Adjusted EBITDA Margin:













Ecoservices


28.3%


32.3%




24.5%


30.9%



Advanced Materials & Catalysts(2)


26.1%


25.4%




28.5%


25.7%



Total Adjusted EBITDA Margin(2)


24.4%


26.8%




22.1%


25.9%



(1)

Represents GAAP sales for the Advanced Silicas business; Excludes our proportionate 50% share of sales from the Zeolyst
Joint Venture.

(2)

Adjusted EBITDA Margin calculation reflects our proportionate 50% share of sales from the Zeolyst Joint Venture.

Appendix Table A-4: Adjusted Free Cash Flow




Six months ended

June 30,



2025


2024



(in millions)

Net cash provided by operating activities


$ 43.3


$ 46.4

Less:





Purchases of property, plant and equipment(1)


(49.5)


(36.6)

Free Cash Flow(2)


$ (6.2)


$ 9.8






Adjustments to free cash flow:





Cash paid for debt financing costs


1.0


4.6

Cash paid for costs related to the Waggaman acquisition


2.8


Adjusted Free Cash Flow(2)


$ (2.4)


$ 14.4






Net cash used in investing activities(3)


$ (90.8)


$ (36.8)

Net cash used in financing activities


$ (29.4)


$ (14.4)

(1)

Excludes the Company's proportionate 50% share of capital expenditures from the Zeolyst Joint Venture.

(2)

We define Adjusted Free Cash Flow as net cash provided by operating activities less purchases of property, plant and
equipment, adjusted for cash flows that are unusual in nature and/or infrequent in occurrence that neither relate to our core
business nor reflect the liquidity of our underlying business. Historically these adjustments include proceeds from the sale
of assets, net interest proceeds on swaps designated as net investment hedges, the cash paid for segment disposals and cash
paid for debt financing costs included in cash from operating activities. Adjusted Free Cash Flow is a non-GAAP financial
measure that we believe will enhance a prospective investor's understanding of our ability to generate additional cash from
operations and is an important financial measure for use in evaluating our financial performance. Our presentation of
Adjusted Free Cash Flow is not intended to replace, and should not be considered superior to, the presentation of our net
cash provided by operating activities determined in accordance with GAAP. Additionally, our definition of Adjusted Free
Cash Flow is limited, in that it does not represent residual cash flows available for discretionary expenditures, due to the
fact that the measure does not deduct the payments required for debt service and other contractual obligations or payments
made for business acquisitions. Therefore, we believe it is important to view Adjusted Free Cash Flow as a measure that
provides supplemental information to our condensed consolidated statements of cash flows. You should not consider
Adjusted Free Cash Flow in isolation or as an alternative to the presentation of our financial results in accordance with
GAAP. The presentation of Adjusted Free Cash Flow may differ from similar measures reported by other companies and
may not be comparable to other similarly titled measures.

(3)

Net cash used in investing activities includes purchases of property, plant and equipment, which is also included in our
computation of Adjusted Free Cash Flow.

Appendix Table A-5: Net Debt Leverage Ratio



June 30, 2025


June 30, 2024


(in millions, except ratios)

Total debt

$ 866.5


$ 873.0

Less:




Cash and cash equivalents

69.6


83.3

Net debt

$ 796.9


$ 789.7





Trailing twelve months:




Net (loss) income

$ (13.8)


$ 56.1

Adjusted EBITDA(1)

$ 230.3


$ 240.1





Net Debt to Net Income ratio

NM


14.1x

Net Debt Leverage ratio

3.5x


3.3x






















(1)

Refer to Appendix Table A-1: Reconciliation of Net Income (Loss) to Adjusted EBITDA for the reconciliation to the most
comparable GAAP financial measure.

Cision View original content to download multimedia:

SOURCE Ecovyst Inc.

FAQ

What were Ecovyst's (ECVT) Q2 2025 earnings results?

Ecovyst reported Q2 2025 sales of $200.1 million and net income of $6.0 million ($0.05 per share). Adjusted EBITDA was $55.7 million with a 24.4% margin.

How much did Ecovyst spend on share repurchases in Q2 2025?

Ecovyst repurchased 2,926,152 shares at an average price of $7.47 per share, totaling $21.9 million.

What is Ecovyst's full-year 2025 guidance?

Ecovyst expects full-year 2025 sales of $795-835 million, Adjusted EBITDA of $242-254 million, and Adjusted Free Cash Flow of $70-80 million.

What was the value of Ecovyst's Waggaman acquisition in 2025?

Ecovyst acquired the Waggaman sulfuric acid production assets for $35.0 million plus $6.3 million in working capital adjustments.

How much liquidity does Ecovyst (ECVT) have as of Q2 2025?

As of June 30, 2025, Ecovyst had total available liquidity of $152.5 million, including $69.6 million in cash and $82.9 million in ABL facility availability.
Ecovyst Inc

NYSE:ECVT

ECVT Rankings

ECVT Latest News

ECVT Latest SEC Filings

ECVT Stock Data

994.38M
115.68M
1.44%
93.04%
4.22%
Specialty Chemicals
Chemicals & Allied Products
United States
WAYNE